Gabapentin Tablets 600mg — Class II drug recall D-0320-2025

Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2025-04-16, distributed nationwide. CGMP Deviations

Recall number	`D-0320-2025`
Product type	Drug
Classification	Class II
Status	Ongoing
Voluntary or mandated	Voluntary
Recalling firm	Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States
Recall initiated	2025-03-13
Classified	2025-04-08
Reported by FDA	2025-04-16
Distributed	Nationwide (US)
Reason classes	cgmp
NDC	`68462-0126`, `68462-0126-01`, `68462-0126-05`, `68462-0127`, `68462-0127-01`, `68462-0127-05`
Lot numbers	`17231015`, `17231128`, `17231138`, `17231139`, `17231143`, `17231144`, `17231256`, `17231386`, `17231387`, `17231407`, `17231417`, `17231418`, `17231754`, `17231848`, `17231898`, `17231977`, `17231978`, `17232015`, `17232016`, `17232017`, `17232034`, `17232041`, `17232396`, `17232406`, `17232410`, `17232490`, `17240085`, `17240117`, `17240131`, `17240326`, `17240327`, `17240383`, `17240395`, `17241863`, `17241869`, `17241870`, `APR-25`, `AUG-25`, `DEC-25`, `FEB-26` and 5 more

Product

Gabapentin Tablets 600mg, 500-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-126-05.

Reason for recall

CGMP Deviations

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0320-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.